Edition:
United Kingdom

People: Cara Therapeutics Inc (CARA.OQ)

CARA.OQ on NASDAQ Stock Exchange Global Market

22.93USD
23 Aug 2019
Change (% chg)

-- (--)
Prev Close
$22.93
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
247,579
52-wk High
$27.50
52-wk Low
$12.20

Posner, Christopher 

Mr. Christopher Posner is Director of the company. Mr. Posner has broad experience in commercial and marketing operations and product management at both large and specialty pharmaceutical companies, where he has focused on products for autoimmune, inflammatory and pain conditions, including Xeljanz® and Enbrel®. Since July 2017, he has been the Chief Executive Officer of LEO Pharma, Inc. US, a subsidiary of LEO Pharma A/S, a global healthcare company specializing in dermatology and critical care, including such conditions as psoriasis and atopic dermatitis. Prior to joining LEO, he was the Head of Worldwide Commercial Operations at R-Pharma-US, LLC, a specialty pharmaceutical company focused on oncology and chronic immune disorders, from 2014 until 2017. Previously, Mr. Posner held a variety of senior management positions in commercial and marketing operations at Bristol-Myers Squibb Company, Pfizer Inc., Wyeth Pharmaceuticals, Inc. and Endo Pharmaceuticals plc. Mr. Posner holds an M.B.A. from Fuqua School of Business, Duke University and a B.A. in Economics from Villanova University. Mr. Posner’s extensive experience in the pharmaceutical industry, including in commercial and marketing operations, provides him with the qualifications to serve on the Board.

Basic Compensation

Total Annual Compensation, USD 24,000
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 470,289
Fiscal Year Total, USD 494,289

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Derek Chalmers

2,789,050

Mani Mohindru

4,046,470

Frederique Menzaghi

1,238,230

Scott Terrillion

--

Joana Goncalves

3,736,190

Martin Vogelbaum

332,261
As Of  31 Dec 2018